Skip to main content

EXXON MOBIL CORP. – Digging deeper into the ground

EXXON MOBIL CORP. – Digging deeper into the ground

EXXON MOBIL CORP.  (NYSE : $XOM) is in a very week configuration. On the yearly trend (lower left price chart) the historical bullish trend appears to have topped in 2014 and has since then stalled inside a contracting triangle. On the weekly chart the stock price has been capped by a descending resistance since mid-2016 […]

Aurinia Pharmaceuticals – Healthy correction to buy

Aurinia Pharmaceuticals – Healthy correction to buy

Aurinia Pharmaceutical ( NASDAQ: $AUPH ) is an absolutely perfect Weinstein play: breakout of resistance line with an explosion of trading volumes, a rising 30-week average, strongly positive relative strength. The stock price follows perfectly the script and offers a new buying opportunity by hitting back the previous resistance line now turned into support line […]

BYD – An electric trap

BYD – An electric trap

The case for BYD (OTC PINK: $BYDDY) – the leading Chinese electric vehicles and renewable energy company – is very clear. The share price is entrapped in a long term contracting triangle and it has been painfully climbing a wall of worries since it bottomed in mid-2011. The 30-week moving average is trending upwards but […]

Editas Medicine – Accumulation phase

Editas Medicine – Accumulation phase

Editas Medicine ( Nasdaq: $EDIT ) is a gene editing company at the leading edge of the revolutionary CRISPR technology. The rising exchange volumes on the weekly scale has the hallmarks of rising interest and shares accumulation, whereas the relative strength is also progressively rising and should soon turn positive. Last week the price broke […]